Estudio en vida real de efectividad de una fórmula hipercalórica hiperproteica en el mantenimiento y mejora del estado nutricional en pacientes con indicación de nutrición enteral a largo plazo

Ballesteros-Pomar, María D.; Carrera, Patricia Sorribes; Piñera, Maria Amparo Rodriguez; Orenes, Antonio Blanco; Romero, Laura; Hernández, Natalia Covadonga Iglesias; Usieto, M. Teresa Olivan; Mas, Francisca Payeras; Benéitez, Margarita Isabel Viñuela; Viveros, María Merino; Aguilera, Cristina; Alcolea, Josefina Olivares

doi:10.1016/j.endinu.2020.03.010

Cited by 6 publications

(4 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In all cases, a favourable clinical course was observed from one visit to the next, with a statistically signi cant reduction in gastrointestinal symptoms at the 3and 6-month visits in terms of tolerance problems, diarrhoea and abdominal distension (Table 6). These ndings are consistent with the Ballesteros et al study in which gastrointestinal adverse reactions were also reduced (nausea, regurgitation, constipation, diarrhoea, atulence and distension), p < 0.05 [24]. A factor that may have affected the good tolerability of HEN may be that 96.8% of our patients had intermittent EN instead of continuous administration.…”

Section: Discussionsupporting

confidence: 92%

“…At 6 months, only one interim suspension (1/390; 0.3%) and two nal suspensions (2/390; 0.5%) occurred from all included patients who had received EN via NGT or ostomy. This fact, together with the low incidence of reported adverse reactions, suggests that overall tolerance must have been good, as was the case in a cohort of 51 patients with HEN treated with a hyperproteic/hypercaloric formula [25].…”

Section: Discussionmentioning

confidence: 88%

See 1 more Smart Citation

Home Enteral Nutrition in Adults: Effectiveness of Nutritional Therapy and Educational Programme

Madrid-Paredes

Leyva-Martínez

Ávila-Rubio

et al. 2021

Preprint

View full text Add to dashboard Cite

PurposeHome Enteral Nutrition (HEN) is used to prevent or correct malnutrition in outpatients. Due to the complexity of this process, the indication, follow-up, and results of an educational programme of HEN patients was evaluated.MethodsA prospective, observational, real-life, multicentre study of patients receiving HEN by nasogastric tube or ostomy in 21 hospitals was conducted. The following variables were collected: age, gender, HEN indication, type of formula, nutritional requirements, laboratory variables, complications, and quality standards of the educational programme. All data were analysed using SPSS.24.Results414 patients were included. Most conditions diagnosed were neurodegenerative diseases (64.8%). 100 patients (25.3%) were diabetic. The mean weight was 59.3±10.4kg and BMI 22.6±3.2. Moderate protein-calorie malnutrition was predominant at baseline (46.4%). Improvement in nutritional status at six months was recorded in more than 75% of patients (p<0.05). Tolerance problems, diarrhoea and abdominal distension fell between the 3- and 6-month visits (p <0.05). Patients who received intermittent Enteral Nutrition (EN) had fewer tolerance-related effects (OR: 0.042; 95% CI: 0.006-0.279) and less diarrhoea (OR: 0.042; 95% CI: 0.006-0.279), while those who received EN via nasogastric tube had fewer tolerance-related effects (OR: 0.042; 95% CI: 0.006-0.279). At the baseline and 6-month visits, compliance with the educational measures proposed by the prescriber was ≥ 99%. ConclusionThe nutritional assessment to prescribe individualised HEN to each patient, together with educational measures and training in the proper use of this treatment for both patients and trainers, improves nutritional status and reduces the onset of adverse reactions.

show abstract

Section: Discussionsupporting

confidence: 92%

Section: Discussionmentioning

confidence: 88%

Home Enteral Nutrition in Adults: Effectiveness of Nutritional Therapy and Educational Programme

Madrid-Paredes

Leyva-Martínez

Ávila-Rubio

et al. 2021

Preprint

View full text Add to dashboard Cite

show abstract

“…In all cases, a favorable clinical course was observed from one visit to the next, with a statistically significant reduction in gastrointestinal symptoms at the 3- and 6-month visits in terms of tolerance problems, diarrhea and abdominal distension (Table 6 ). These findings are consistent with the Ballesteros et al study in which gastrointestinal adverse reactions were also reduced (nausea, regurgitation, constipation, diarrhea, flatulence and distension), p < 0.05 [ 25 ]. A factor that may have affected the good tolerability of HEN may be that 96.8% of our patients had intermittent EN instead of continuous administration.…”

Section: Discussionsupporting

confidence: 92%

“…At 6 months, only one interim suspension (1/390; 0.3%) and two final suspensions (2/390; 0.5%) occurred from all included patients who had received EN via NGT or PEG. This fact, together with the low incidence of reported adverse reactions, suggests that overall tolerance must have been good, as was the case in a cohort of 51 patients with HEN treated with a hyperproteic/hypercaloric formula [ 26 ].…”

Section: Discussionmentioning

confidence: 99%

Impact of nutritional and educational support on home enteral nutrition

Madrid-Paredes

Leyva-Martínez

Ávila-Rubio

et al. 2023

J Health Popul Nutr

View full text Add to dashboard Cite

Background Home Enteral Nutrition (HEN) is used to prevent or correct malnutrition in outpatients. Due to the complexity of this process, the indication, follow-up, and results of an educational program of HEN patients was evaluated. Methods A prospective, observational, real-life, multicenter study was performed in 21 Spanish Hospital. Patients receiving HEN by nasogastric tube or ostomy were included. The following variables were collected: age, gender, HEN indication, type of formula, nutritional requirements, laboratory variables, complications, and quality standards of the educational program. To calculate the energy and protein requirements, the FAO/WHO/UNU formula was used considering the adjusted weight of the patients. All data were analyzed using SPSS.24. Results 414 patients were included. Most conditions diagnosed were neurodegenerative diseases (64.8%). 100 (25.3%) were diabetic. The mean weight was 59.3 ± 10.4 kg and BMI 22.6 ± 3.2. Moderate protein-calorie malnutrition was predominant at baseline (46.4%). Improvement in nutritional status at six months was recorded in more than 75% of patients (p < 0.05). Tolerance problems, diarrhea and abdominal distension fell between the 3- and 6-month visits (p < 0.05). Patients who received intermittent EN had fewer tolerance-related effects (OR 0.042; 95% CI 0.006–0.279) and less diarrhoea (OR 0.042; 95% CI 0.006–0.279). At the baseline and 6-month visits, compliance with the educational measures proposed by the prescriber was ≥ 99%. Conclusion The nutritional assessment to prescribe individualized HEN to each patient, together with educational measures and training in the proper use of this treatment for both patients and trainers, improves nutritional status and reduces the onset of adverse events.

show abstract

Quality of life assessment instruments in adult patients receiving home parenteral and enteral nutrition: A scoping review

et al. 2022

View full text Add to dashboard Cite

Quality of life (QoL) assessment is important to evaluate the effect of the intervention for patients treated with home parenteral and enteral nutrition (HPEN). The purpose of this scoping review is to describe, evaluate, and recommend QoL instruments used in adult patients receiving HPEN. We used the Arksey and O'Malley framework and performed literature searches in five databases (PubMed, CINAHL, EMBASE, Web of Science, and Cochrane Library) to identify possibly relevant articles that focused on QoL of adult patients receiving HPEN. Of the studies that qualify for full-text screening, two independent researchers extracted data. Twenty-seven QoL instruments were identified, consisting of seven generic instruments, 12 disease-specific instruments, and eight therapy-specific instruments. The Short Form-36 was the most widely used generic instrument and the European Organization for Research and Treatment of Cancer QLQ-C30 was the most commonly employed disease-specific instrument. The recently developed therapy-specific tools, NutriQoL and HPN-QoL, were increasingly employed in studies either alone or in combination with other types of instruments. Important aspects of each instrument were summarized to aid clinicians and researchers in selecting an appropriate instrument when measuring the QoL of adult HPEN patients. Findings could also help to identify the necessity to develop new tools or to modify pre-existing ones to measure QoL of HPEN patients.

show abstract

Estudio en vida real de efectividad de una fórmula hipercalórica hiperproteica en el mantenimiento y mejora del estado nutricional en pacientes con indicación de nutrición enteral a largo plazo

Cited by 6 publications

References 11 publications

Home Enteral Nutrition in Adults: Effectiveness of Nutritional Therapy and Educational Programme

Home Enteral Nutrition in Adults: Effectiveness of Nutritional Therapy and Educational Programme

Impact of nutritional and educational support on home enteral nutrition

Quality of life assessment instruments in adult patients receiving home parenteral and enteral nutrition: A scoping review

Contact Info

Product

Resources

About